Session

Liver & biliary (Posters)

ASSOCIATION OF OXIDATIVE STRESS WITH THE SEVERITY OF LIVER FIBROSIS IN PATIENTS WITH OPISTHORCHIS FELINEUS INVASION
ASSOCIATION OF OXIDATIVE STRESS WITH THE SEVERITY OF LIVER FIBROSIS IN PATIENTS WITH OPISTHORCHIS FELINEUS INVASION

Liver & biliary (Posters)  et al.

THE SUBPOPULATION COMPOSITION OF BLOOD T-KILLERS AND THE FREQUENCY OF SEVERE LIVER FIBROSIS DIFFER IN PATIENTS WITH VIRAL HEPATITIS C WITH GENOTYPES 1 AND 3 IN THE INDUSTRIAL CENTER OF EASTERN SIBERIA
THE SUBPOPULATION COMPOSITION OF BLOOD T-KILLERS AND THE FREQUENCY OF SEVERE LIVER FIBROSIS DIFFER IN PATIENTS WITH VIRAL HEPATITIS C WITH GENOTYPES 1 AND 3 IN THE INDUSTRIAL CENTER OF EASTERN SIBERIA

Liver & biliary (Posters)  et al.

PREVALANCE AND SIGNIFICANCE OF ASYMPTOMATIC CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS INFECTIONS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE - TO TREAT OR IGNORE?
PREVALANCE AND SIGNIFICANCE OF ASYMPTOMATIC CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS INFECTIONS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE - TO TREAT OR IGNORE?

Liver & biliary (Posters)  et al.

QUALITY OF LIFE IMPROVEMENT IS A TOP-RATED BUT RARELY ASSESSED OUTCOME IN EUROPEAN AND AUSTRALIAN PATIENTS WITH HEPATIC ENCEPHALOPATHY: QUALITY OF LIFE TARGETING AND MONITORING NEEDS TO BE PRIORITISED
QUALITY OF LIFE IMPROVEMENT IS A TOP-RATED BUT RARELY ASSESSED OUTCOME IN EUROPEAN AND AUSTRALIAN PATIENTS WITH HEPATIC ENCEPHALOPATHY: QUALITY OF LIFE TARGETING AND MONITORING NEEDS TO BE PRIORITISED

Liver & biliary (Posters)  et al.

MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING FOR THE DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING FOR THE DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS

Liver & biliary (Posters)  et al.

LIVER TRANSAMINASES, LEPTIN AND INTERLEUKIN-6 LEVEL IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH OBESITY AND ARTERIAL HYPERTENSION DURING TREATMENT WITH URSODEOXYCHOLIC ACID, STATINS AND SARTANS
LIVER TRANSAMINASES, LEPTIN AND INTERLEUKIN-6 LEVEL IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH OBESITY AND ARTERIAL HYPERTENSION DURING TREATMENT WITH URSODEOXYCHOLIC ACID, STATINS AND SARTANS

Liver & biliary (Posters)  et al.

HEPATOCELLULAR CARCINOMA (HCC) AWARENESS AND SURVEILLANCE IN PATIENTS WITH CHRONIC LIVER DISEASES (CLD) FOLLOWED IN TERTIARY GREEK LIVER CENTERS
HEPATOCELLULAR CARCINOMA (HCC) AWARENESS AND SURVEILLANCE IN PATIENTS WITH CHRONIC LIVER DISEASES (CLD) FOLLOWED IN TERTIARY GREEK LIVER CENTERS

Liver & biliary (Posters)  et al.

THE SYNERGISTIC EFFECTS OF IFN-GAMMA AND IL-1BETA ON THE MECHANISM OF PROGRAMMED CELL DEATH 1 LIGAND 1 EXPRESSION IN HEPATOCELLULAR CARCINOMA
THE SYNERGISTIC EFFECTS OF IFN-GAMMA AND IL-1BETA ON THE MECHANISM OF PROGRAMMED CELL DEATH 1 LIGAND 1 EXPRESSION IN HEPATOCELLULAR CARCINOMA

Liver & biliary (Posters)  et al.

PROCALCITONIN AS A PROGNOSTIC TOOL IN THE MANAGEMENT OF REFRACTORY ASCITES
PROCALCITONIN AS A PROGNOSTIC TOOL IN THE MANAGEMENT OF REFRACTORY ASCITES

Liver & biliary (Posters)  et al.

MICRORNA-122 CONJUGATED POLYMER NANOPARTICLES AS A PROTECTIVE TOOL AGAINST DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN AN EXPERIMENTAL MODEL
MICRORNA-122 CONJUGATED POLYMER NANOPARTICLES AS A PROTECTIVE TOOL AGAINST DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN AN EXPERIMENTAL MODEL

Liver & biliary (Posters)  et al.

DIP THE TAP - IMPROVING NEEDLE TO DIAGNOSIS TIME IN SPONTANEOUS BACTERIAL PERIOTINITIS: A RENEWED SCREENING ROLE FOR BEDSIDE LEUCOCYTE ESTERASE TEST KITS - DURING COVID 19 PANDEMIC: A MULTISITE STUDY
DIP THE TAP - IMPROVING NEEDLE TO DIAGNOSIS TIME IN SPONTANEOUS BACTERIAL PERIOTINITIS: A RENEWED SCREENING ROLE FOR BEDSIDE LEUCOCYTE ESTERASE TEST KITS - DURING COVID 19 PANDEMIC: A MULTISITE STUDY

Liver & biliary (Posters)  et al.

DIETARY PATTERNS IN PATIENTS WITH SIMPLE STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS: PROSPECTIVE COMPARATIVE TRIAL
DIETARY PATTERNS IN PATIENTS WITH SIMPLE STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS: PROSPECTIVE COMPARATIVE TRIAL

Liver & biliary (Posters)  et al.

ASSOCIATION OF GLUTATHIONE-S-TRANSFERASE GENES DELETION POLYMORPHISM WITH THE ECHOCARDIOGRAPHIC PREDICTORS OF MYOCARDIAL HYPERTROPHY IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
ASSOCIATION OF GLUTATHIONE-S-TRANSFERASE GENES DELETION POLYMORPHISM WITH THE ECHOCARDIOGRAPHIC PREDICTORS OF MYOCARDIAL HYPERTROPHY IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS

Liver & biliary (Posters)  et al.

PREVALENCE AND RISK FACTORS ASSOCIATED WITH PROGRESSION TO ADVANCED FIBROSIS AND CIRRHOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): ANALYSIS OF A PROSPECTIVE REGISTRY
PREVALENCE AND RISK FACTORS ASSOCIATED WITH PROGRESSION TO ADVANCED FIBROSIS AND CIRRHOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): ANALYSIS OF A PROSPECTIVE REGISTRY

Liver & biliary (Posters)  et al.

THE SYSTEMIC INFLAMMATORY RESPONSE IDENTIFIES PATIENTS WITH ADVERSE CLINICAL OUTCOME FROM IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA
THE SYSTEMIC INFLAMMATORY RESPONSE IDENTIFIES PATIENTS WITH ADVERSE CLINICAL OUTCOME FROM IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA

Liver & biliary (Posters)  et al.

ACCURACY OF FIB-4 AND HEPAMET FIBROSIS SCORE TO IDENTIFY ADVANCED LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
ACCURACY OF FIB-4 AND HEPAMET FIBROSIS SCORE TO IDENTIFY ADVANCED LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Liver & biliary (Posters)  et al.

UNDERSTANDING THE TRANSCRIPTOMIC CHANGES OF MAFLD IN HIGH FAT DIET MURINE MODELS AND ITS REVERSION BY ANTI-STEATOTIC TREATMENTS THROUGH META-ANALYSIS
UNDERSTANDING THE TRANSCRIPTOMIC CHANGES OF MAFLD IN HIGH FAT DIET MURINE MODELS AND ITS REVERSION BY ANTI-STEATOTIC TREATMENTS THROUGH META-ANALYSIS

Liver & biliary (Posters)  et al.

PREDICTION OF ESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: EXTERNAL VALIDATION OF COOK COUNTY SCORE
PREDICTION OF ESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: EXTERNAL VALIDATION OF COOK COUNTY SCORE

Liver & biliary (Posters)  et al.

WHAT IS THE CLINICAL IMPACT OF ASCITES CHOLESTEROL AND PROBNP LEVELS IN OUR ROUTINE PRACTICE FOR THE DIFFERENTIAL DIAGNOSIS OF ASCITES ETIOLOGY?
WHAT IS THE CLINICAL IMPACT OF ASCITES CHOLESTEROL AND PROBNP LEVELS IN OUR ROUTINE PRACTICE FOR THE DIFFERENTIAL DIAGNOSIS OF ASCITES ETIOLOGY?

Liver & biliary (Posters)  et al.

DISTINCTIVE CLINICAL FEATURES OF NON-ALCOHOLIC AND MIXED FATTY LIVER DISEASE
DISTINCTIVE CLINICAL FEATURES OF NON-ALCOHOLIC AND MIXED FATTY LIVER DISEASE

Liver & biliary (Posters)  et al.

Item 161 - 180 / 270
1 2 3 4 5 6 7 8
9
10 11 12 13 14